Mr Samir Kaul

KANDO id: 9960

Bio

Samir is a Founding Partner and Managing Director at Khosla Ventures, where he focuses on health, sustainability, food, and advanced technology investments. Samir led the firm’s investments in Cadre, Guardant Health [NASDAQ: GH], Impossible Foods, Mojo Vision, NanoH2O (acquired by LG Chem), Nutanix [NASDAQ: NTNX], Oscar, Quantumscape, and Ultima, among others. Prior to co-founding Khosla Ventures, Samir spent five years at Flagship Ventures where he started and invested in early-stage biotechnology companies. While there, he was involved in co-founding Helicos BioSciences [IPO], a leader in developing single-molecule sequencing instruments to revolutionize personalized medicine, along with Stan Lapidus and Steve Quake of Stanford. Samir was also founding CEO of Codon Devices, where he raised their Series A financing, built the technical and advisory teams, and booked significant revenues in the company’s first year of operations. His other investments include Epitome [acquired by Millipore], LS9 [acquired by REG] and Morphotek [acquired by Eisai]. Previously, Samir led the Arabidopsis Genome Initiative at Craig Venter’s Institute for Genomic Research. Under his direction, the project was completed early and cost-efficiently, culminating in a historic publication in the scientific journal Nature in December 2000. Samir is active in philanthropy and has been a longstanding member of the leadership committee of the Tipping Point Community. He is also a board member of UCSF Benioff Children’s Hospital and on the Board of Trustees for the US Ski and Snowboard Association.

Career


Khosla Ventures - founder

Venture capital firm founded by Vinod Khosla.
Focus on health, sustainability, food, and advanced technology investments.
Focus on health, sustainability, food, and advanced technology investments.
Email: [email protected]

Codon Devices Inc - founder


Flagship Ventures

Venture capital firm
N/A (past)

Education